Winning pharma brands: Changing the rules of a market
Understanding the bigger questions that winning pharma brands ask to change the market and redefine the playing field. The global health emergency that we are...
Pf Webinars: Pharma and Integrated Care Systems – How to make your brand relevant
Pf is proud to announce a new FREE webinar series with Triducive. The first webinar, focuses on pharma and integrated care systems. In this...
Why are life science companies contracting market access activities?
Sathyanarayanan Krishnamurthy, Vice President – Regulatory Operations at Freyr Solutions looks at contracting out market access activities and how this frees up life sciences...
Mind the generation gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
The art of customer experience management (CXM)
Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy.
“ACROSS...
The key to engaging healthcare professionals effectively
Hank Sczerba on how to understand healthcare professionals in order to target them more effectively
Tell me about yourself and what you do? I am Head...
Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
Latest articles
Antibiotic Research UK launches small research grants programme
Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-Oncology drug to enter clinical trials
Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
New COVID-19 test reduces testing time from 30 minutes to five
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
First AI-designed Immuno-Oncology drug to enter clinical trials
Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...